Zomedica (ZOM) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
24 Apr, 2026Executive summary
Annual meeting scheduled for June 10, 2026, to be held virtually via live audio webcast, allowing real-time participation and voting for registered shareholders and proxyholders.
Notice-and-access model used for meeting materials, with instructions for accessing documents online and options for requesting paper copies.
Shareholders encouraged to vote in advance by proxy, with detailed instructions provided in the management information circular.
Voting matters and shareholder proposals
Election of eight director nominees to serve until the next annual meeting.
Ratification of Grant Thornton LLP as independent registered public accounting firm for 2026.
Advisory vote to approve executive compensation for named executive officers.
Amendment to company by-laws regarding quorum requirements for adjourned meetings.
Consideration of any other matters properly brought before the meeting.
Board of directors and corporate governance
Board recommends voting "FOR" all director nominees and all other proposals on the agenda.
Latest events from Zomedica
- Record Q2 revenue up 37% year-over-year, net loss down 49%, and strong liquidity supports growth.ZOM
Q2 2026 - Five-pillar sales strategy and cross-selling drive strong revenue growth and expanding market presence.ZOM
Investor update - Five Pillars strategy fuels recurring revenue, efficiency, and global growth toward profitability.ZOM
Investor update - Q1 2026 revenue up 35% to $8.8M, with strong margins, lower losses, and improved cash burn.ZOM
Q1 2026 - Strong growth and innovation in animal health technology drive expanding market leadership.ZOM
Investor presentation - Virtual meeting to vote on directors, auditor, executive pay, and by-law amendment; Board is majority independent.ZOM
Proxy filing - AI-driven platforms and recurring revenue fuel growth, with profitability targeted by 2027.ZOM
Status update - Virtual meeting to vote on directors, auditor, executive pay, and by-law changes; board is majority independent.ZOM
Proxy filing - Record revenue growth and strong margins, with new segments and cost controls driving performance.ZOM
Q4 2025